Lineage Cell Therapeutics
LCTX
#8759
Rank
NZ$0.43 B
Marketcap
NZ$1.71
Share price
-4.01%
Change (1 day)
-44.85%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -NZ$46.76 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are NZ$13.08 Million. In 2025 the company made an earning of -NZ$38.97 Million a decrease over its 2024 earnings that were of -NZ$38.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$46.76 Million19.97%
2025 -NZ$38.97 Million1.4%
2024 -NZ$38.44 Million-13.16%
2023 -NZ$44.26 Million9.83%
2022 -NZ$40.3 Million-54.24%
2021 -NZ$88.06 Million86.07%
2020 -NZ$47.33 Million-31.97%
2019 -NZ$69.57 Million-5.42%
2018 -NZ$73.55 Million1.1%
2017 -NZ$72.75 Million-31.06%
2016 -NZ$0.11 Billion-10.38%
2015 -NZ$0.12 Billion29.69%
2014 -NZ$90.79 Million31.68%
2013 -NZ$68.95 Million
2011 -NZ$33.46 Million89.78%
2010 -NZ$17.64 Million206.06%
2009 -NZ$5.77 Million-0.58%
2008 -NZ$5.8 Million164.89%
2007 -NZ$2.19 Million-30.22%
2006 -NZ$3.14 Million
2002 -NZ$3.65 Million-41.04%
2001 -NZ$6.18 Million-32.04%
2000 -NZ$9.09 Million-11.85%
1999 -NZ$10.31 Million
1997 -NZ$6.63 Million12.12%
1996 -NZ$5.91 Million106.25%
1995 -NZ$2.87 Million-11.11%
1994 -NZ$3.23 Million50%
1993 -NZ$2.15 Million20%
1992 -NZ$1.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.28 Billion 481.52%๐Ÿ‡บ๐Ÿ‡ธ USA